Back
Cognizant Technology Solutions Vs. Kymera Therapeutics Industry Stock Comparison
Buy
57
CTSH
Cognizant Technology Solutions
Last Price:
74.60
Seasonality Move:
12.42%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.17
Seasonality Move:
69.6%
Buy
57
Cognizant Technology Solutions (CTSH)
is a Buy
Is Cognizant Technology Solutions a Buy, Sell or Hold?
- The current Cognizant Technology Solutions [CTSH] share price is $74.36. The Score for CTSH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CTSH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CTSH Stock Price Chart
What is Cognizant Technology Solutions's stock price today?
-
The Cognizant Technology Solutions share price today is $74.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTSH is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
CTSH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 40.56 | Sell |
Chaikin Money Flow: | -2193962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.25 - 77.21) | Sell |
Bollinger Bands (100): | (69.96 - 77.46) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 52.44 | Buy |
Chaikin Money Flow: | -88534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.05 - 49.09) | Buy |
Bollinger Bands (100): | (36.61 - 48.91) | Buy |
CTSH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.42 | Sell |
20-day SMA: | 76.14 | Sell |
50-day SMA: | 76.36 | Sell |
200-day SMA: | 73.15 | Buy |
8-day EMA: | 75.37 | Sell |
20-day EMA: | 75.89 | Sell |
50-day EMA: | 75.64 | Sell |
200-day EMA: | 72.93 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.2 | Sell |
20-day SMA: | 46.01 | Buy |
50-day SMA: | 47.06 | Buy |
200-day SMA: | 39.57 | Buy |
8-day EMA: | 47.93 | Sell |
20-day EMA: | 47.19 | Buy |
50-day EMA: | 46.06 | Buy |
200-day EMA: | 39.32 | Buy |
Cognizant Technology Solutions Earnings Growth & CTSH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.36 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Cognizant Technology Solutions Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |